Sonnet BioTherapeutics

1 follower

‌

Sonnet’s proprietary FHAB™ (Fully Human Albumin Binding) technology enables the development of innovative targeted biologic drugs with enhanced single- or bi-specific mechanisms.

Industries

Biotechnology

Headquarters

Princeton, United States

Employees

11-50

Links

Org chart

Pankaj Mohan

Founder, CEO & Chairman

Pankaj Mohan

Collapse

John K. Cini

Chief Scientific Officer & Co Founder

Jay Cross

CFO

Susan Dexter

Chief Technical Officer

Richard Kenney

Chief Medical Officer

Stephen J. McAndrew

Vice President, Business Development

Kal Ghosh

Executive Administrative Assistant

Teams

Directors

5 members

Leadership Team

5 members

Advisory Team

4 members

Similar companies

UNITY Biotechnology

12 followers

Natera

13 followers

NeoGenomics

8 followers

Spark Therapeutics

7 followers

Idexx Laboratories

7 followers

Legend Biotech

5 followers

Merck

213 followers

AbbVie

176 followers

Achillestx

3 followers

Tempus Labs

16 followers

Amgen

211 followers

Explore companies